Private Equity Profile
In the last 3 years, Aisling Capital has acquired 1 company. It has also invested in 2 others.
Aisling Capital’s most common sectors for investment are life science (72%) and medical products (22%). The Firm’s most common investment types include venture (56%) and stake purchase (19%). In total, Aisling Capital has invested in 13 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Catalent for $3.3B.
In the last 3 years, Aisling Capital has exited 3 companies. The Firm’s most common exit type is trade sale (75%). Aisling Capital’s largest (disclosed) exit occurred in 2017 when it sold ZELTIQ Aesthetics for $2.5B.
Join Mergr to view Aisling Capital’s full profile and discover more large private equity firms just like it.
M&A Total Activity69
- M&A Buy Activity38
- M&A Sell Activity31
- Total Sectors Invested 4
- Total Countries Invested 2
- M&A Buy/Sell Connections 32
- M&A Advisors 3